A novel albumin nanoplatform containing MnO2 efficiently delivers PDT, including PS IR780, as well as NLG919 and paclitaxel dimer, providing a simultaneous solution to the problems of tumor hypoxia, enhancement of ICD induction, and modulation of immunosuppressive TME. Here, ALB is linked to neoplasm.